These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 25827549)

  • 41. A case of Vogt-Koyanagi-Harada disease with good visual acuity in spite of subfoveal fold.
    Noda Y; Sonoda KH; Nakamura T; Kawano YI; Ishibashi T; Inomata H
    Jpn J Ophthalmol; 2003; 47(6):591-4. PubMed ID: 14636850
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Particular aspects of the Vogt-Koyanagi Harada syndrome.
    Manor RS
    Ophthalmologica; 1972; 165(5):425-37. PubMed ID: 4680208
    [No Abstract]   [Full Text] [Related]  

  • 43. Serous Macular Detachment in Probable Vogt-Koyanagi-Harada Syndrome.
    Li AS; Tang PH; Do DV
    JAMA Ophthalmol; 2020 May; 138(5):e191981. PubMed ID: 32407448
    [No Abstract]   [Full Text] [Related]  

  • 44. Self-Reported Quality of Life in Patients with Long-Standing Vogt-Koyanagi-Harada Disease.
    Missaka RFBG; Souto FMS; Albornoz NCA; Gaspar Carvalho da Silva FTB; Lavezzo MM; Oyamada MK; Hirata CE; Yamamoto JH
    Ocul Immunol Inflamm; 2020 Apr; 28(3):409-420. PubMed ID: 31136253
    [No Abstract]   [Full Text] [Related]  

  • 45. Correlation between sunset glow fundus and initial dosage of corticosteroid in patients with Vogt-Koyanagi-Harada disease.
    Guo YL; Du Y; He JF
    Am J Ophthalmol; 2009 May; 147(5):946; author reply 946-7. PubMed ID: 19376333
    [No Abstract]   [Full Text] [Related]  

  • 46. Azathioprine During the First Trimester of Pregnancy in a Patient with Vogt-Koyanagi-Harada Disease: A Multimodal Imaging Follow-Up Study.
    Ingolotti M; Schlaen BA; Roig Melo-Granados EA; Ruiz García H; Aguilera Partida JA
    Am J Case Rep; 2019 Mar; 20():300-305. PubMed ID: 30842390
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vogt-Koyanagi-Harada syndrome and pregnancy.
    Steahly LP
    Ann Ophthalmol; 1990 Feb; 22(2):59-62. PubMed ID: 2316953
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vogt-Koyanagi-Harada disease: clinical and demographic characteristics of patients in a specialized eye hospital in Turkey.
    Ozdal P; Ozdamar Y; Yazici A; Teke MY; Ozturk F
    Ocul Immunol Inflamm; 2014 Aug; 22(4):277-86. PubMed ID: 24328424
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Optical Coherence Tomography Angiography and En Face Optical Coherence Tomography Features of Paracentral Acute Middle Maculopathy.
    Sridhar J; Shahlaee A; Rahimy E; Hong BK; Khan MA; Maguire JI; Dunn JP; Mehta S; Ho AC
    Am J Ophthalmol; 2015 Dec; 160(6):1259-1268.e2. PubMed ID: 26386158
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intravitreal bevacizumab injection in a 14-year-old Vogt-Koyanagi-Harada patient with choroidal neovascular membrane.
    Raffa L; Bawazeer A
    Can J Ophthalmol; 2009 Oct; 44(5):615-6. PubMed ID: 19789612
    [No Abstract]   [Full Text] [Related]  

  • 51. Subretinal neovascular membranes in Vogt-Koyanagi-Harada syndrome.
    Moorthy RS; Chong LP; Smith RE; Rao NA
    Am J Ophthalmol; 1993 Aug; 116(2):164-70. PubMed ID: 8352300
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ultra-wide-field green (532 nm) and red (633 nm) reflectance imaging of the "sunset glow" fundus in chronic Vogt-Koyanagi-Harada disease.
    Ahn SE; Kim SW; Oh J; Huh K
    Indian J Ophthalmol; 2013; 61(1):38-9. PubMed ID: 23275222
    [No Abstract]   [Full Text] [Related]  

  • 53. Acute retinal necrosis (ARN) following chickenpox in a patient of Vogt-Koyanagi-Harada (VKH) syndrome using immunosuppressants.
    Gupta R; Tyagi M; Balakrishnan D; Rani PK
    BMJ Case Rep; 2018 Nov; 11(1):. PubMed ID: 30567136
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Objective evaluation of choroidal melanin loss in patients with Vogt-Koyanagi-Harada disease using polarization-sensitive optical coherence tomography.
    Miura M; Makita S; Yasuno Y; Azuma S; Mino T; Yamaguchi T; Iwasaki T; Nemoto R; Shimizu H; Goto H
    Sci Rep; 2022 Mar; 12(1):3526. PubMed ID: 35241784
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Utility of existing Vogt-Koyanagi-Harada syndrome diagnostic criteria at initial evaluation of the individual patient: a retrospective analysis.
    Read RW; Rao NA
    Ocul Immunol Inflamm; 2000 Dec; 8(4):227-34. PubMed ID: 11262652
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inflammation of the posterior uvea: findings on fundus fluorescein and indocyanine green angiography.
    Altan-Yaycioglu R; Akova YA; Akca S; Yilmaz G
    Ocul Immunol Inflamm; 2006 Jun; 14(3):171-9. PubMed ID: 16766401
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Choroidal folds in acute Vogt-Koyanagi-Harada disease.
    Zhao C; Zhang M; Wen X; Dong F; Han B; Du H
    Ocul Immunol Inflamm; 2009; 17(4):282-8. PubMed ID: 19657984
    [TBL] [Abstract][Full Text] [Related]  

  • 58. RETINAL PIGMENT EPITHELIUM UNDULATIONS IN ACUTE STAGE OF VOGT-KOYANAGI-HARADA DISEASE: Biomarker for Functional Outcomes After High-Dose Steroid Therapy.
    Hashizume K; Imamura Y; Fujiwara T; Machida S; Ishida M; Kurosaka D
    Retina; 2016 Feb; 36(2):415-21. PubMed ID: 26352553
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tomographic features of serous retinal detachment in Vogt-Koyanagi-Harada syndrome.
    Maruyama Y; Kishi S
    Ophthalmic Surg Lasers Imaging; 2004; 35(3):239-42. PubMed ID: 15185793
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Distinguishing Microvasculature Features of Vogt-Koyanagi-Harada in Patients in Acute and Convalescent Phases Using Optical Coherence Tomography Angiography.
    Luo K; Cai H; Hu Y; Jin C; Gan X; Deng Y; Lu M; Chen H; Su L; Chen G; Chi W
    Ocul Immunol Inflamm; 2021 Apr; 29(3):465-471. PubMed ID: 31900010
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.